Using a Modified Lymphocyte Genome Sensitivity (LGS) Test or TumorScan Test to Detect Cancer at an Early Stage in Each Individual

Autor: Anderson, Diana, Najafzadeh, Mojgan, Scally, Andy J., Jacob, B.K., Griffith, John, Chaha, R., Linforth, R., Soussaline, M., Soussaline, F.

Yes
Our previous case-control study observed isolated lymphocytes from 208 individuals and determined the differences in the sensitivity to genomic damage of lymphocytes derived from cancer patients, pre/suspect cancer patients and healthy volun

Externí odkaz: http://hdl.handle.net/10454/17765

Using a Modified Lymphocyte Genome Sensitivity (LGS) test or TumorScan test to detect cancer at an early stage in each individual.

Autor: Anderson D; School of Life Sciences University of Bradford Bradford UK., Najafzadeh M; School of Life Sciences University of Bradford Bradford UK., Scally A; Faculty of Health Studies University of Bradford Bradford UK., Jacob B; Bradford Teaching Hospitals NHS Foundation Trust, Bradford Royal Infirmary Bradford UK., Griffith J; Bradford Teaching Hospitals NHS Foundation Trust, Bradford Royal Infirmary Bradford UK., Chaha R; Bradford Teaching Hospitals NHS Foundation Trust, Bradford Royal Infirmary Bradford UK., Linforth R; Bradford Teaching Hospitals NHS Foundation Trust, Bradford Royal Infirmary Bradford UK., Soussaline M; IMSTAR SAS Paris France., Soussaline F; IMSTAR SAS Paris France.

Publikováno v: FASEB bioAdvances [FASEB Bioadv] 2018 Dec 20; Vol. 1 (1), pp. 32-39. Date of Electronic Publication: 2018 Dec 20 (Print Publication: 2019).